AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca share of after-tax losses of associates and joint ventures ($M) ($M)
Consolidated Income Statement (Postgres DB)
Latest, FY2025
-7
Period ended Dec 31, 2025
Change on a year earlier
-75.0%
-28 in FY2024
History
11 years
Since FY2015
Sources
9
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Share of after-tax losses of associates and joint ventures ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | -7 | -75.0% | Form 20-F (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | -28 | +133.3% | Form 20-F (filed 2025-02-18) ↗ |
| FY2023 | Dec 31, 2023 | -12 | +140.0% | Form 20-F (filed 2024-02-20) ↗ |
| FY2022 | Dec 31, 2022 | -5 | -92.2% | Form 20-F (filed 2023-02-21) ↗ |
| FY2021 | Dec 31, 2021 | -64 | +137.0% | Form 20-F (filed 2022-02-22) ↗ |
| FY2020 | Dec 31, 2020 | -27 | -76.7% | Form 20-F (filed 2021-02-16) ↗ |
| FY2019 | Dec 31, 2019 | -116 | +2.7% | Form 20-F (filed 2020-03-03) ↗ |
| FY2018 | Dec 31, 2018 | -113 | +105.5% | Form 20-F (filed 2019-03-05) ↗ |
| FY2017 | Dec 31, 2017 | -55 | +66.7% | Form 20-F (filed 2018-03-06) ↗ |
| FY2016 | Dec 31, 2016 | -33 | +106.3% | Form 20-F (filed 2018-03-06) ↗ |
| FY2015 | Dec 31, 2015 | -16 | – | Form 20-F (filed 2018-03-06) ↗ |
Cite this data
StockData. (2026). AstraZeneca Share of after-tax losses of associates and joint ventures ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/fin_eq_inc
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.